Betahistine Mesylate API

Name	Betahistine Mesylate
Chinese name	甲磺酸倍他司汀
Cas Number	54856-23-4
Source	Europe
Qualifications	-/-/-/-/-

Betahistine mesylate is a vasodilator developed by Japan Eisai Co., Ltd. and is a histamine drug. As a strong H3 receptor antagonist, betahistine mesylate can increase inner ear microcirculation, reduce vestibular afferent nerve discharge rate, enhance central vestibular compensation, and improve blood supply to the vertebral base artery, thereby effectively improving various causes Caused by vertigo. In the study of the treatment of schizophrenia and other serious mental illnesses, compared with taking olanzapine alone, patients who took both olanzapine and betahistine mesylate at the same time had better curative effects; in addition to that In addition, the combination of betahistine mesylate and olanzapine can also greatly enhance the safety of drug treatment of psychosis, and can also reduce the risk of malignant weight gain in patients to a certain extent. From 2015 to 2019, the market capacity of betahistine mesylate increased from 336 million yuan to 987 million yuan. Among them, urban public hospitals accounted for 50% of sales, while county-level public hospitals increased from 14.13% to 37.36%, showing a rapid growth trend. The market demand and development potential of related varieties are huge.

Hot Tags: betahistine mesylate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Oseltamivir Phosphate API, Pabxilib API, Pregabalin API, Solinasine Succinate API, Aprepitant Aprepitant API, Canagliflozin API

• Previous: Nicardipine Hydrochloride API
• Next: Fluorometholone API